Could surgery boost immunotherapy for stomach cancer?

NCT ID NCT06468280

First seen Feb 01, 2026 · Last updated May 14, 2026 · Updated 17 times

Summary

This study is for people with stomach cancer that has spread to a few other places in the body. It tests whether adding surgery to remove the main tumor and some of the spread, along with other local treatments, to a combination of immunotherapy and chemotherapy helps people live longer without the cancer getting worse. About 84 people will take part, and half will get the extra surgery while the other half gets only the drug treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Zhongshan Hospital Fudan University

    NOT_YET_RECRUITING

    Shanghai, Shanghai City, 200032, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Zhongshan Hospital, Fudan University

    RECRUITING

    Shanghai, Shanghai Municipality, 201000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.